{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:03:13Z","timestamp":1778922193295,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Wave Life Sciences Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.clinthera.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T07:28:09Z","timestamp":1608967689000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lessons from an Experiential Approach to Patient Community Engagement in Rare Disease"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6563-2576","authenticated-orcid":false,"given":"Jeffrey","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Damm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Hover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.12.002_bib1","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.2196\/resprot.6902","article-title":"Engaging patients and caregivers managing rare diseases to improve the methods of clinical guideline development: a research protocol","volume":"6","author":"Khodyakov","year":"2017","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.clinthera.2020.12.002_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MLR.0000000000000273","article-title":"Patient-focused drug development: a new direction for collaboration","volume":"53","author":"Perfetto","year":"2015","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2020.12.002_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00005110-200302000-00004","article-title":"Making patient-centered care come alive: achieving full integration of the patient's perspective","volume":"33","author":"Ponte","year":"2003","journal-title":"J\u00a0Nurs Adm"},{"key":"10.1016\/j.clinthera.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bmjinnov-2016-000157","article-title":"Defining patient centricity with patients for patients and caregivers: a collaborative endeavour","volume":"3","author":"Yeoman","year":"2017","journal-title":"BMJ Innov"},{"key":"10.1016\/j.clinthera.2020.12.002_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13023-018-0761-2","article-title":"Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases","volume":"13","author":"Stein","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinthera.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.healthpol.2012.02.018","article-title":"How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction","volume":"105","author":"Budych","year":"2012","journal-title":"Health Policy"},{"key":"10.1016\/j.clinthera.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13023-015-0281-2","article-title":"How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration","volume":"10","author":"Furlong","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinthera.2020.12.002_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13023-019-1173-7","article-title":"Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy","volume":"14","author":"Denger","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinthera.2020.12.002_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/dmcn.13934","article-title":"Duchenne muscular dystrophy and caregiver burden: a systematic review","volume":"60","author":"Landfeldt","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clinthera.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19180","article-title":"Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders","volume":"19","author":"Uttley","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clinthera.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"e1559","DOI":"10.1542\/peds.2012-0858","article-title":"Health-related quality of life in children and adolescents with Duchenne muscular dystrophy","volume":"130","author":"Uzark","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/03007995.2018.1440199","article-title":"Project Transform: engaging patient advocates to share their perspectives on improving research, treatment and policy","volume":"34","author":"Bridges","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2020.12.002_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jval.2016.02.014","article-title":"Developing a patient-centered benefit-risk survey: a community-engaged process","volume":"19","author":"Hollin","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s11136-018-1891-7","article-title":"Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy","volume":"27","author":"Hollin","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clinthera.2020.12.002_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.clinthera.2014.04.011","article-title":"A\u00a0community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy","volume":"36","author":"Peay","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2020.12.002_bib16","series-title":"Anorexia and Bulimia Nervosa","article-title":"Storytelling as a therapeutic tool for family support in bulimia nervosa","author":"Qui\u00f1ones","year":"2019"},{"key":"10.1016\/j.clinthera.2020.12.002_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1258\/jhsrp.2010.009160","article-title":"Storylines of self-management: narratives of people with diabetes from a multiethnic inner city population","volume":"16","author":"Greenhalgh","year":"2011","journal-title":"J\u00a0Health Serv Res Policy"},{"key":"10.1016\/j.clinthera.2020.12.002_bib18","article-title":"Group-based storytelling in disease self-management among people with diabetes","volume":"1742395319859395","author":"Gucciardi","year":"2019","journal-title":"Chronic Illness"},{"key":"10.1016\/j.clinthera.2020.12.002_bib19","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0140-6736(08)60875-2","article-title":"Empowerment of patients: lessons from the rare diseases community","volume":"371","author":"Aym\u00e9","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.12.002_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13012-018-0784-z","article-title":"Engaging patients to improve quality of care: a systematic review","volume":"13","author":"Bombard","year":"2018","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2020.12.002_bib21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/2168479015580384","article-title":"Partnering with patients in the development and lifecycle of medicines: a call for action","volume":"49","author":"Hoos","year":"2015","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.clinthera.2020.12.002_bib22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jval.2016.04.009","article-title":"Increasing patient involvement in drug development","volume":"19","author":"Lowe","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2020.12.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40271-017-0264-6","article-title":"Making patient engagement a reality","volume":"11","author":"Pushparajah","year":"2018","journal-title":"Patient"},{"key":"10.1016\/j.clinthera.2020.12.002_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13023-017-0738-6","article-title":"Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review","volume":"12","author":"Young","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinthera.2020.12.002_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1472-6963-14-89","article-title":"Patient engagement in research: a systematic review","volume":"14","author":"Domecq","year":"2014","journal-title":"BMC Health Serv Res"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182030549X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182030549X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:55:00Z","timestamp":1758963300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182030549X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S014929182030549X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.12.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from an Experiential Approach to Patient Community Engagement in Rare Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}